$1.330
0.000 (0.00%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Allogene Therapeutics, Inc. (ALLO) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting ALLO is Strong sell.
Allogene Therapeutics, Inc. (ALLO) 20-Day simple moving average is 1.45, while Allogene Therapeutics, Inc. (ALLO) share price is $—, making it Sell.
Allogene Therapeutics, Inc. (ALLO) 60-Day simple moving average is 1.77, while Allogene Therapeutics, Inc. (ALLO) share price is $—, making it Sell.
Technical Analysis for ALLO
AI Technical ALLOAs of 2026-10-17, the technical board for Allogene Therapeutics, Inc. (ALLO) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $1.33 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 30.613, MACD stands at -0.12 (Sell), Stochastic %K stands at 25.687, Stochastic %D stands at 23.278 and CCI stands at -71.014.
ALLO trades below the 60-day SMA (1.77) and below the 200-day SMA (1.99). Immediate resistance sits at Classic R1 1.48, then R2 1.61. Support sits at Classic S1 1.22, then S2 1.09.
Allogene Therapeutics, Inc. (ALLO) Support & Resistance Level
Allogene Therapeutics, Inc. (ALLO) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 30.613 |
| STOCHk_14_3_3 | 25.687 |
| STOCHd_14_3_3 | 23.278 |
| CCI_20 | -71.014 |
| AO_5_34 | -0.270 |
| MOM_10 | -0.100 |
| MACD_12_26_9 | -0.120 |
Allogene Therapeutics, Inc. (ALLO) Relative Strength Index (RSI_14) is 30.613, creating a Neutral signal.
Allogene Therapeutics, Inc. (ALLO) Stochastic %K is 25.687, creating a Neutral signal.
Allogene Therapeutics, Inc. (ALLO) Stochastic %D is 23.278, creating a Neutral signal.
Allogene Therapeutics, Inc. (ALLO) CCI_20 is -71.014, creating a Neutral signal.
Allogene Therapeutics, Inc. (ALLO) Awesome Oscillator (AO) is -0.270, creating a Sell signal.
Allogene Therapeutics, Inc. (ALLO) Momentum (MOM) is -0.100, creating a Sell signal.
Allogene Therapeutics, Inc. (ALLO) Moving Average Convergence Divergence (MACD) is -0.120, creating a Sell signal.
Allogene Therapeutics, Inc. (ALLO) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.322 | Buy |
| MA_10 | 1.346 | Sell |
| MA_20 | 1.453 | Sell |
| MA_60 | 1.772 | Sell |
| MA_200 | 1.992 | Sell |
| MA_250 | 1.859 | Sell |
Allogene Therapeutics, Inc. (ALLO) 5-Day simple moving average is 1.322, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Buy.
Allogene Therapeutics, Inc. (ALLO) 10-Day simple moving average is 1.346, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
Allogene Therapeutics, Inc. (ALLO) 20-Day simple moving average is 1.453, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
Allogene Therapeutics, Inc. (ALLO) 60-Day simple moving average is 1.772, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
Allogene Therapeutics, Inc. (ALLO) 200-Day simple moving average is 1.992, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
Allogene Therapeutics, Inc. (ALLO) 250-Day simple moving average is 1.859, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.